Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Megace ES (Megestrol Acetate) Oral Suspension
Company: Par Pharmaceutical Inc.
Application No.:  021778
Approval Date: 07/05/2005


Date created:  July 02, 2007

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.